Susquehanna International Group’s OncoSec Medical Incorporated ONCS Stock Holding History

Susquehanna International Group’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,829	Closed	-$30K	–	14690
2022 Q3	$30K	Buy	2,829 +626	+28%	+$9.41K	﹤0.01%	12453
2022 Q2	$36K	Sell	2,203 -806	-27%	-$15.5K	﹤0.01%	12148
2022 Q1	$76K	Buy	3,009 +1,006	+50%	+$21.2K	﹤0.01%	12087
2021 Q4	$42K	Buy	2,003 +685	+52%	+$23.2K	﹤0.01%	12641
2021 Q3	$62K	Buy	+1,318	New	+$66.8K	﹤0.01%	12278
2019 Q2	–	Sell	-51	Closed	-$6K	–	11237
2019 Q1	$6K	Buy	+51	New	+$6.97K	﹤0.01%	8674
2017 Q3	–	Sell	-46	Closed	-$12K	–	10059
2017 Q2	$12K	Buy	+46	New	+$11.3K	﹤0.01%	9066
2017 Q1	–	Sell	-100	Closed	-$27K	–	10546
2016 Q4	$27K	Buy	+100	New	+$34.3K	﹤0.01%	9394

Other funds holding ONCS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's ONCS Position: Q4 2022 in Review

Susquehanna International Group sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 2,829 shares — an estimated $30K sold.

Susquehanna International Group first reported a position in ONCS in Q4 2016 and held it in 8 quarters. The position peaked at $76K in Q1 2022. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

Susquehanna International Group reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
Susquehanna International Group sold 2,829 OncoSec Medical Incorporated shares in Q4 2022, an estimated $30K.
Susquehanna International Group first reported a position in OncoSec Medical Incorporated in Q4 2016 and held it in 8 quarters.
Susquehanna International Group's OncoSec Medical Incorporated position peaked at $76K in Q1 2022.
17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.